Consumer Staples · Perfumes, Cosmetics & Other Toilet Preparations

KVUE Kenvue SEC Filings & Insider Trading Activity 2026

company
CIK 1944048127 filings
S&P 500

KVUE at a glance

Kenvue (KVUE, SEC CIK 1944048) filed its latest 10-K annual report on February 20, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as November 4, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 28, 2025 (FY2025), Kenvue (KVUE) reported revenue of $15.1 billion (down 2.1% from FY2024) and net income of $1.5 billion. Diluted EPS was $0.76.
  • As of September 30, 2026, 40 institutional investment managers tracked by SignalX reported holding Kenvue (KVUE) shares worth $13.8 billion in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$15.1B
−2.1% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
40 funds
$13.8B · −1 vs prior quarter
Latest 8-K
Nov 4, 2026
Item 3.03

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 28, 2025

Full analysis →

Business Overview

  • Core business: Global pure-play consumer health company with $15.1B FY2025 sales, focused on Self Care, Skin Health & Beauty, and Essential Health segments
  • New emphasis: Completed full independence from J&J by August 2023, exiting TSAs and building standalone systems and capabilities
  • Strategic shift: Entered merger agreement with Kimberly-Clark in Nov 2025, aiming to combine consumer health and personal care portfolios
  • Quantitative metrics: Approximately 22,000 employees globally as of Dec 2025, with 23% in North America, 28% EMEA, 30% APAC, 19% LATAM
  • Noteworthy fact: FY2025 in-house manufacturing covered 60% of sales volume, rest from third-party suppliers, supporting global operational flexibility

Risk Factors

  • Regulatory risk from Section 368(a) Internal Revenue Code uncertainty; potential additional U.S. federal income taxes if Proposed Transaction fails to qualify as a “reorganization”
  • Geopolitical/macroeconomic risk with inflationary pressures and raw material cost volatility linked to military conflicts and tariffs
  • Operational risk from reliance on third-party manufacturing and supply chains causing potential disruptions to operations
  • Competitive risk from intense competition across all segments from multinational corporations, smaller regional companies, private-label, and generic products
  • Financial risk due to increased Kimberly-Clark indebtedness from Proposed Transaction financing, reducing cash flow available for debt servicing and increasing liquidity risk

Management Discussion & Analysis

  • Operating cash flow $2.2B in FY 2025, up $428M from $1.8B in FY 2024, driven by working capital timing in payables and receivables
  • Financing cash outflow $1.8B in FY 2025 vs $1.6B in FY 2024; included $1.58B dividends, $197M share repurchases, $750M debt repayment, $746M long-term notes issuance
  • Capital expenditures $475M in FY 2025, slight increase from $425M investing outflows in prior year
  • Share repurchases totaled $197M for ~9.18M shares before merger agreement restriction; no repurchases post-merger agreement signed Nov 2025
  • Management expects sufficient liquidity from $1.1B cash, $2.2B operating cash flow, $4B credit facility, and $4B commercial paper; warns financing availability risk

AI summary of the KVUE 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 27, 2026

Risk Factors

  • No material changes disclosed, risks remain those identified in the most recent Annual Report
  • Carried-forward regulatory, operational, competitive, market, and financial risks incorporated by reference to the Annual Report

Management Discussion & Analysis

  • Quarterly revenue $3,886M, up $122M or 3.2% YoY, organic sales up 2.9%
  • Gross margin 59.5% vs 59.1% YoY, SG&A margin 40.4% vs 40.2%
  • Best segment Self Care: revenue $1,656M, up 5.9%; worst Skin Health and Beauty: organic sales down 0.5%
  • Operating cash flow $1,877M, up $534M; cash $1,039M, down $23M
  • Headwinds: Middle East input inflation and tariffs; 2026 restructuring expected to cost $250M and save $200M annually

AI summary of the KVUE 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 4, 2026Full analysis →

Item 3.03: Material Modification to Rights of Security Holders

  • Exchange completed November 4, 2026, with $6,376,039,000 of Kenvue notes tendered, accepted and canceled
  • Remaining Kenvue debt sharply reduced, including $260,653,000 due 2028 and $153,011,000 due 2030
Filed Nov 2, 2026Full analysis →

Item 1.02: Termination of a Material Definitive Agreement

  • $4.0B five-year senior unsecured revolving credit facility terminated at First Merger closing
  • No borrowings outstanding, limiting direct balance-sheet impact from the facility termination

Item 2.01: Completion of Acquisition or Disposition of Assets

  • Kenvue shares converted into 0.14625 K-C shares plus $3.50 cash per share
  • Kenvue shareholders now hold K-C equity, replacing standalone Kenvue ownership

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule

  • NYSE trading suspension tied to completed first merger, ending public-market trading in Kenvue common stock
  • Form 25 delisting effective 10 days after filing, removing Kenvue shares from NYSE

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • 12 pre-merger directors resigned at the First Effective Time, signaling complete board turnover under the merger structure
  • Courtney Roane and Flavio Costa became initial surviving-company directors, while five merger-sub officers assumed operating roles

Item 5.03: Amendments to Articles of Incorporation or Bylaws

  • Kenvue Inc. converted its surviving entity into “Kenvue LLC” following the second merger
  • New certificate of formation became effective at the second merger closing

Item 8.01: Other Events

  • Successor company assumed Kenvue’s obligations under $7.0B of outstanding senior notes
  • Debt spans maturities from 2028 through 2063, preserving existing bondholder claims after the merger
Filed Oct 30, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q3 net sales rose 3.2% to $3.886B, with organic growth of 2.9% and volume growth of 1.6%
  • Adjusted operating margin expanded to 21.9% from 21.5%, supported by productivity and cost optimization initiatives

Item 2.02: Results of Operations and Financial Condition

  • Kenvue announced fiscal third-quarter results for the period ended September 27, 2026
  • Investors should review Exhibit 99.1 for revenue, profitability, guidance and business-segment performance details

AI summaries of KVUE 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for KVUE

Don't miss the next KVUE filing

  • Alerts as it files. A push when KVUE files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut KVUE, by share count.
  • Ask anything. An AI agent that reads every KVUE filing and answers with sources.

KVUE alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Dasgupta AnindyaDNov 2, 2026-
Dasgupta AnindyaDNov 2, 2026-
Smith Jeffrey CDNov 2, 2026-
Dasgupta AnindyaDNov 2, 2026-
Hofstetter SarahDNov 2, 2026-
Halvorson JonathanDNov 2, 2026-
ALLISON RICHARD E JRDNov 2, 2026-
ALLISON RICHARD E JRDNov 2, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$15.5B$15.1B
Gross Profit-$9.0B$8.8B
Operating Income-$1.8B$2.4B
Net Income-$1.0B$1.5B
Gross Margin-58.0%58.1%
Op. Margin-11.9%16.0%
Net Margin-6.7%9.7%
Balance Sheet
Total Assets$27.9B$25.6B$27.1B
Equity$11.2B$9.7B$10.8B
ROE-10.7%13.7%
Per Share
EPS-$0.54$0.76
Cash Flow
Operating CF-$1.8B$2.2B
CapEx-$434.0M$475.0M

Source: XBRL data in Kenvue (KVUE)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate KVUE share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
KVUE shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202640$13.85B
Q2 202641$17.88B
Q1 202641$15.56B
Q4 202538$14.80B
Q3 202542$16.60B
Q2 202540$22.35B
Q1 202537$18.47B
Q4 202431$14.12B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 310 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

KVUE filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
8-KNov 4, 2026Analysis-
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
4Nov 4, 2026--
8-KNov 2, 2026Analysis-
4Nov 2, 2026--
4Nov 2, 2026--

Related Consumer Staples companies

All Consumer Staples →

KVUE SEC filings: frequently asked questions

Which institutions hold KVUE stock?

As of September 30, 2026, the largest Kenvue (KVUE) holders among the 13F filers tracked by SignalX were BlackRock ($2.7 billion), Vanguard Capital Management LLC ($2.2 billion), State Street Corp ($2.1 billion), Vanguard Portfolio Management LLC ($1.6 billion), Millennium Management ($611.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was KVUE's revenue in fiscal year 2025?

For the fiscal year ended December 28, 2025 (FY2025), Kenvue (KVUE) reported revenue of $15.1 billion (down 2.1% from FY2024) and net income of $1.5 billion. Diluted EPS was $0.76. The figures come from the XBRL data in the 10-K.

What are the main risks in KVUE's latest 10-K?

In the 10-K filed February 20, 2026, Kenvue (KVUE) flagged: Regulatory risk from Section 368(a) Internal Revenue Code uncertainty; potential additional U.S. federal income taxes if Proposed Transaction fails to qualify as a “reorganization”. Geopolitical/macroeconomic risk with inflationary pressures and raw material cost volatility linked to military conflicts and tariffs. (AI summary of the Risk Factors section.)

What did KVUE report in its latest 8-K?

Kenvue (KVUE) filed an 8-K on November 4, 2026 reporting Item 3.03 (Material Modification to Rights of Security Holders). Exchange completed November 4, 2026, with $6,376,039,000 of Kenvue notes tendered, accepted and canceled.

What are the latest KVUE SEC filings?

Kenvue (KVUE) filed its latest 10-K annual report on February 20, 2026, a 10-Q quarterly report on October 30, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on November 4, 2026.

What is KVUE's SEC CIK number?

Kenvue (KVUE)'s SEC Central Index Key (CIK) is 1944048. EDGAR lists every KVUE filing under that number.

Ask anything about KVUE

The research agent reads KVUE's filings, financials, insider trades and 13F holders, then answers with sources.